Amirouchene-Angelozzi, Nabil

IFOM

1 paper on CoChat

Most cited papers

Verified
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial
Siena, S., Sartore-Bianchi, A., Personeni, N., Pietrantonio, F., Germano, G., Amatu, A., Bonoldi, E., Valtorta, E., Barault, L., Di Nicolantonio, F., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies
Cited by 15

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free